Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The Asia Pacific infant, child, and maternal probiotic supplements market is expected to grow from US$ 201.82 million in 2022 to US$ 346.65 million by 2028; it is estimated to grow at a CAGR of 9.4% from 2022 to 2028.

Many prominent manufacturers of probiotics are investing in research and development to develop reliable and science-backed probiotic supplements for infants and pregnant women. Further, they are conducting research to gain a deeper understanding of probiotics' benefits for infants, children, and expecting mothers. New research published in the Journal Microorganisms stated that probiotic supplementation during late pregnancy or lactation and breastfeeding could reduce the risk of mastitis. Similarly, in April 2019, DSM, a major food and nutritional ingredient manufacturer, conducted a study on the effects of probiotic supplementation in reducing infant colic in breastfed babies. BioCare, a fully owned subsidiary of DSM, funded this study and used probiotic strains, namely Lactobacillus rhamnosus and Lactobacillus reuteri, on breastfed babies aged 4 to 12 weeks for 28 days. The study found that breastfed babies supplemented with probiotics were less exposed to colic. The overall cry and fuss time was reduced by 163 minutes.

With the growing demand for infant and maternal probiotics products, manufacturers are innovating their products to increase their customer base and boost revenues. They are launching convenient probiotic delivery formats, such as drops, sticks, sachets, gummies, and powder, for easy consumption by infants and toddlers. These convenient delivery formats of probiotic supplements are gaining high acceptance in Asia Pacific. Thus, such R&D activities and growing studies on probiotic supplements are expected to boost the infant, child, and maternal probiotic supplements market growth over the forecast period.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Revenue and Forecast to 2028 (US$ Thousand)

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Segmentation

The market for Asia Pacific infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the Asia Pacific infant, child, and maternal probiotic supplements market is segmented into China, Japan, Australia, New Zealand, and the Rest of Asia Pacific.

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market -Companies Mentioned

Bayer Corporation, Nestle S.A., BioGaia AB, and Nordic Naturals are a few major companies operating in the Asia Pacific infant, child, and maternal probiotic supplements market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027129

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study
3.2 Research Methodology
- 3.2.1 Data Collection:
- 3.2.2 Primary Interviews:
- 3.2.3 Hypothesis Formulation:
- 3.2.4 Macro-economic Factor Analysis:
- 3.2.5 Developing Base Number:
- 3.2.6 Data Triangulation:
- 3.2.7 Country Level Data:
- 3.2.8 Limitations and Assumptions:

4. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis

5. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
- 5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
- 5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
- 5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
- 5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints

6. Asia Pacific Infant, Child, and Maternal Probiotic Supplements -Market Analysis

6.1 Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)

7. Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

7.1 Overview
7.2 Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
- 7.3.1 Overview
- 7.3.2 Capsules and Softgels: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
- 7.4.1 Overview
- 7.4.2 Gummies: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
- 7.5.1 Overview
- 7.5.2 Liquid: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

8.1 Overview
8.2 Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
- 8.3.1 Overview
- 8.3.2 Infant and Toddler: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
- 8.4.1 Overview
- 8.4.2 Children: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
- 8.5.1 Overview
- 8.5.2 Maternal Women: Asia Pacific Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market - Country Analysis

9.1 Asia Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market
- 9.1.1 Asia Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
- 9.1.2 Asia Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.1.2.1 China: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.1.1 China: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.1.2.1.2 China: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.2 Japan: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.2.1 Japan: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.1.2.2.2 Japan: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.3 Australia: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.3.1 Australia: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.1.2.3.2 Australia: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.4 New Zealand: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.4.1 New Zealand: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.1.2.4.2 New Zealand: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.5 Rest of Asia Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.5.1 Rest of Asia-Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.1.2.5.2 Rest of Asia-Pacific: Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview
10.2 Product launch
10.3 Expansion

11. Company Profiles

11.1 Bayer Corporation
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Nestle S.A.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 BioGaia AB
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nordic Naturals
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Word Index